Actinium Pharmaceuticals
Peter James Baker has a strong background in the pharmaceutical industry, with extensive experience in drug substance/drug product manufacturing, production management, and research. Peter James currently serves as the Director of Drug Substance/Drug Product Manufacturing at Actinium Pharmaceuticals, Inc. Prior to this, they worked as the Head of Production at Advanced Accelerator Applications and as a Senior Manager at Regeneron Pharmaceuticals, Inc. Peter James has also held roles as a Senior Specialist at MSD, Scientist at Teva Pharmaceuticals, and Principal Scientist at Eurofins Lancaster Laboratories. Additionally, they have gained research experience as a Postdoctoral Research Fellow at RIKEN and as a Visiting Research Fellow at Zhejiang University of Technology. Peter began their career as a Graduate Research Fellow at Polytechnic Institute of New York University and as a Research Technician at Weill Cornell Medical College.
Peter James Baker obtained a PhD in Biomedical Engineering from the Polytechnic Institute of New York University, starting in 2007 and completing in 2011.
This person is not in any offices
Actinium Pharmaceuticals
Actinium Pharmaceuticals is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.